Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma.
about
Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -DExpression of Serum Sialic Acid, Early Antigen-IgA, and Viral Capsid Antigen-IgA in Nasopharynx Cancer Patients: The Diagnostic Implication of Combined AssaysExpression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma.Overview of the 8th Edition TNM Classification for Head and Neck Cancer.Tumor DNA: an emerging biomarker in head and neck cancer.Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA.The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma.Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
P2860
Q35887274-55B310C4-3389-4087-B6A6-D2A7616E32C2Q36425762-674C014A-E973-45B0-9C93-63288C021848Q36511863-52972901-FC04-4B65-AB77-ADDED5400729Q37738086-D22DC9A5-BAFF-4576-A3F5-47BADF3233D7Q39337270-D71A0E7C-E7F2-466D-B1C8-B59B92349347Q40085419-E0686A4C-50E5-48C3-903E-FD0D5E168666Q40163936-10E6E72B-7F06-4488-96DC-97ADA91CD9BCQ41093379-D1ECDC68-5D16-45F5-AED6-1007411B54FCQ42145376-4D9863DB-B44D-4322-8BC1-1CB51C7F8A3AQ47099520-B4136550-6DE1-4D63-B6CD-2915B688D2AC
P2860
Serologic biomarkers of Epstein-Barr virus correlate with TNM classification according to the seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Serologic biomarkers of Epstei ...... for nasopharyngeal carcinoma.
@en
Serologic biomarkers of Epstei ...... for nasopharyngeal carcinoma.
@nl
type
label
Serologic biomarkers of Epstei ...... for nasopharyngeal carcinoma.
@en
Serologic biomarkers of Epstei ...... for nasopharyngeal carcinoma.
@nl
prefLabel
Serologic biomarkers of Epstei ...... for nasopharyngeal carcinoma.
@en
Serologic biomarkers of Epstei ...... for nasopharyngeal carcinoma.
@nl
P2093
P2860
P1476
Serologic biomarkers of Epstei ...... for nasopharyngeal carcinoma.
@en
P2093
Li-Zhi Liu
Xin-Lin Chen
Yi-Kan Cheng
Zhi-Jian Zeng
P2860
P2888
P304
P356
10.1007/S00405-013-2805-5
P577
2013-11-09T00:00:00Z